The American Society of Clinical Oncologists (ASCO) has declared immunotherapy the Clinical Advance Of The Year for the second year running – a sentiment that is very much shared by the cancer research community as a whole. The term immunotherapy as a whole refers to therapeutic strategies that utilize the patient’s own immune system to fight cancer – an idea that is rooted in some exciting research dating back to the 1980s and that is now really coming into its own with the development of sophisticated technologies.
CAR-T immunotherapy is one of the two recent immunotherapy technologies that have shaken the
If our reporting has informed or inspired you, please consider making a donation. Every contribution, no matter the size, empowers us to continue delivering accurate, engaging, and trustworthy science and medical news. Independent journalism requires time, effort, and resources—your support ensures we can keep uncovering the stories that matter most to you.
Join us in making knowledge accessible and impactful. Thank you for standing with us!